Newly approved medicinal products - November 2023
18.12.2023
more
News and Educations
Newly approved medicinal products - October 2023
15.11.2023
more
Direct healthcare professional communication on the risk of atrial fibrillation associated with the use of medicinal products containing Omega-3-acid ethyl esters
08.11.2023
more
Direct healthcare professional communication on new restrictions to prevent topiramate exposure in pregnancy
02.11.2023
more
Information to marketing authorisation holders regarding variation applications after referral for topiramate-containing medicinal products
27.10.2023
more
Newly approved medicinal products - September 2023
16.10.2023
more
Obligation to submit a variation application following PSUSA procedure
18.09.2023
more
Newly approved medicinal products - August 2023
15.09.2023
more
Newly approved medicinal products - July 2023
16.08.2023
more
Obligation to submit a variation application following PSUSA procedure
14.07.2023
more
